Arbele

Arbele Limited is a biotech company that specialises in treatment of gastrointestinal cancers. Arbele pioneered the use of CDH17 biomarker that targets solid tumours together with Tibtech (Tiberias Technology, a subsidiary of the Arbele biotechnology company).